| Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) |
Committee, Work group, Advisory group, or Task Force |
CDC, SAMHSA |
NIAAA, NIDA |
ICCPUD provides national leadership in federal policy and programming to support state and community activities that prevent and reduce underage drinking. ICCPUD develops the Comprehensive Plan for preventing and reducing underage drinking. |
| Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA |
NCATS, NCI, NIEHS, NLM, OD/DPCPSI/ORIP |
The ICCVAM Authorization Act outlines the following purposes of ICCVAM: Increase the efficiency and effectiveness of U.S. federal agency test method review.Eliminate unnecessary duplication of effort and share experience among U.S. federal regulatory agencies.Optimize utilization of scientific expertise outside the U.S. federal government.Ensure that new and revised test methods are validated to meet the needs of U.S. federal agencies.Reduce, refine, or replace the use of animals in testing where feasible. |
| Interagency Coordination on Firearm Violence and Community Violence |
Committee, Work group, Advisory group, or Task Force |
CDC |
NINR, OD/DPCPSI/OBSSR |
N/A |
| Interagency Elder Justice Working Group |
Committee, Work group, Advisory group, or Task Force |
ACL, ASPE, CDC, HRSA, OASH |
NIA |
The Elder Justice Interagency Working Group (EJWG) provides continuous input and support to the Elder Justice Coordinating Council (EJCC), which was established in response to the Elder Justice Act. The EJWG is comprised of federal officials responsible for carrying out elder justice activities, including elder abuse prevention, research, grant and program funding, and prosecution. Since 2012, members have met regularly to discuss emerging issues, promising practices, and ways to coordinate their efforts. |
| Interagency Group for Development of Lung Infection Models for P. aeruginosa and A.baumannii |
Committee, Work group, Advisory group, or Task Force |
BARDA, CDC, FDA |
NIAID |
This interagency working group meets quarterly to discuss the development of various lung infection animal models. |
| Interagency Group on Alzheimer's Disease and Related Dementias for implementation of the National Alzheimer's Project Act |
Committee, Work group, Advisory group, or Task Force |
ACL, AHRQ, AoA, ASPE, CDC, CMS, HRSA, IHS, OASH, SAMHSA |
NIA |
This interagency group was established by Department of Health and Human Services (HHS) in response to the Congressional directive to address Alzheimer disease. The group works to carry out the National Alzheimer’s Project Act’s charges to coordinate research and services across agencies, accelerate the development of AD/ADRD treatments, improve early diagnosis and coordination of care, reduce ethnic and racial disparities in rates of AD/ADRD, and coordinate with international efforts to fight these conditions. |
| Interagency Hazard Communication Working Group |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA |
NCI, OD/DPCPSI/OBSSR |
This group coordinates hazard communication research and implementation needs across the Federal government, and is co-led by DCCPS Senior Scientist Paul Han. |
| Interagency High Containment Laboratory Working Group |
Committee, Work group, Advisory group, or Task Force |
ASPR, CDC, FDA |
OD/OM, OD/OM/ORS |
The purpose is to fulfill strategies for the Interim Strategy for Federal High Containment Laboratories. |
| Interagency Modeling and Analysis Group (IMAG) |
Committee, Work group, Advisory group, or Task Force |
AHRQ, BARDA, CDC, FDA |
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, OD/DPCPSI/OBSSR, OD/DPCPSI/ODS |
The purpose of the IMAG is to provide an open forum for communication among government representatives to share updates on individual programs from the various IMAG agencies, and to plan trans-agency activities that will have a broad impact on the communities served by the IMAG. https://www.imagwiki.nibib.nih.gov/content/msm-participants |
| Interagency Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Working Group |
Committee, Work group, Advisory group, or Task Force |
CDC |
NIAID, NINDS |
The Interagency ME/CFS Working Group consists of multiple government agencies and patient ME/CFS patient advocacy organizations interested in research and care issues related to ME/CFS. The working group was established to help coordinate ME/CFS-related efforts across the federal agencies to enhance research efforts, improve treatment options and patient outcomes, promote public outreach, and strengthen workforce development. The working group, which is co-led by NINDS and CDC, met for the first time in August 2020, and will continue to meet regularly to provide updates, discuss issues relevant to ME/CFS research, and identify and foster communication and collaboration across the federal agencies and with ME/CFS stakeholders. |